发明名称 Use of S-Nitrosothiol Signaling to Treat Disordered Control of Breathing
摘要 The present invention is directed to a method of treating disordered control of breathing including the treatment of apnea and hypoventilation associated with congenital or acquired brain stem abnormalities. Specifically the invention is directed to treating disordered control of breathing by administering an S-nitrosylating agent selected from the group consisting of ethylnitrite, glutathione, nitric oxide, S-nitrosocysteine, S-nitrosoglutathione, S-nitroso-L-cysteinyl glycine, N-acetyl cysteine and S-nitroso-N-acetyl cysteine. As shown in FIG. 1C the ability of endogenous SNOs to increase VE in freely behaving, conscious rats using whole-body plethysmography revealed that CSNO, GSNO and CGSNO (1 nmol each) caused equivalent increases in VE, whereas D-CSNO had no effect (left bar graph is the control whereas the right bar represents administration of the respective SNO).
申请公布号 US2011177000(A1) 申请公布日期 2011.07.21
申请号 US201113072979 申请日期 2011.03.28
申请人 UNIVERSITY OF VIRGINIA PATENT FOUNDATION 发明人 GASTON BENJAMIN M.;GOZAL DAVID
分类号 A61K49/00;A61K31/00;A61K31/198;A61K31/21;A61K33/00;A61K38/05;A61K38/06;A61P11/00 主分类号 A61K49/00
代理机构 代理人
主权项
地址